April 29, 2014
USA Today (4/29, Painter) reports that for years, “the Food and Drug Administration has…required antidepressants to carry warnings that they may increase the risk of suicidal thinking and behavior in children and adults under age 25.” Now, a study published online April 28 in JAMA Internal Medicine “finds the risk for deliberate self harm doubles when depressed young people start treatment with higher-than-usual doses.” Researchers arrived at this conclusion after examining “health records of 162,625 privately insured people ages 10 to 64 treated for depression with three popular antidepressants…Celexa [citalopram], Prozac [fluoxetine] and Zoloft [sertraline].”
[Read more…]